Xiaojing Guo

4.6k total citations
151 papers, 3.2k citations indexed

About

Xiaojing Guo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaojing Guo has authored 151 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 49 papers in Oncology and 29 papers in Cancer Research. Recurrent topics in Xiaojing Guo's work include Breast Cancer Treatment Studies (18 papers), Pharmacovigilance and Adverse Drug Reactions (17 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Xiaojing Guo is often cited by papers focused on Breast Cancer Treatment Studies (18 papers), Pharmacovigilance and Adverse Drug Reactions (17 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Xiaojing Guo collaborates with scholars based in China, United States and Sweden. Xiaojing Guo's co-authors include Li Fu, Jia He, Ronggang Lang, Xiaofei Ye, Feng Gu, Xinmin Zhang, Jinfang Xu, Bo Xu, Li Fu and Fangyuan Hu and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaojing Guo

144 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojing Guo China 35 1.2k 905 759 432 329 151 3.2k
Gary Gordon United States 35 1.4k 1.2× 1.0k 1.1× 484 0.6× 386 0.9× 239 0.7× 105 4.4k
Shengli Yang China 33 2.0k 1.8× 1.0k 1.1× 845 1.1× 313 0.7× 480 1.5× 167 4.0k
Jaydutt V. Vadgama United States 41 2.4k 2.1× 1.6k 1.7× 879 1.2× 485 1.1× 400 1.2× 130 4.5k
Elaine Lai‐Han Leung Macao 40 2.6k 2.2× 1.1k 1.3× 748 1.0× 267 0.6× 531 1.6× 143 4.7k
Liling Zhang China 32 1.3k 1.1× 1.2k 1.3× 746 1.0× 298 0.7× 299 0.9× 145 3.9k
Si Sun China 28 1.4k 1.2× 857 0.9× 737 1.0× 155 0.4× 319 1.0× 147 2.9k
Saverio Candido Italy 31 2.2k 1.9× 1.1k 1.2× 996 1.3× 202 0.5× 528 1.6× 80 3.7k
Haibo Wang China 27 1.2k 1.1× 677 0.7× 486 0.6× 170 0.4× 242 0.7× 165 2.5k
Neil Murphy France 25 1.1k 0.9× 1.1k 1.3× 492 0.6× 437 1.0× 177 0.5× 71 3.4k
Howard H. Bailey United States 35 1.9k 1.6× 865 1.0× 391 0.5× 553 1.3× 227 0.7× 108 4.2k

Countries citing papers authored by Xiaojing Guo

Since Specialization
Citations

This map shows the geographic impact of Xiaojing Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Guo more than expected).

Fields of papers citing papers by Xiaojing Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Guo. The network helps show where Xiaojing Guo may publish in the future.

Co-authorship network of co-authors of Xiaojing Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojing Guo. A scholar is included among the top collaborators of Xiaojing Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojing Guo. Xiaojing Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Jifeng, Tanxi Cai, Lili Niu, et al.. (2025). Optimization and assessment of an integrated workflow for the isolation and proteomic analysis of small urinary extracellular vesicles (suEVs). SHILAP Revista de lepidopterología. 5. 100076–100076. 1 indexed citations
3.
Yang, Bo‐Yi, Xiaojing Guo, Gang Liu, et al.. (2024). Alterations in purine and pyrimidine metabolism associated with latent tuberculosis infection: insights from gut microbiome and metabolomics analyses. mSystems. 9(11). e0081224–e0081224. 4 indexed citations
4.
Huang, Yanqi, Guoqiang Han, Zhenwei Shi, et al.. (2024). FedDBL: Communication and Data Efficient Federated Deep-Broad Learning for Histopathological Tissue Classification. IEEE Transactions on Cybernetics. 54(12). 7851–7864. 6 indexed citations
5.
6.
Cao, Xiaoqiong, Hengjun Du, Xiaojing Guo, et al.. (2023). Adverse effects of titanium dioxide nanoparticles on beneficial gut bacteria and host health based on untargeted metabolomics analysis. Environmental Research. 228. 115921–115921. 10 indexed citations
7.
Guo, Xiaojing, et al.. (2023). Design, synthesis, activity and molecular dynamics studies of 1,3,4-thiadiazole derivatives as selective allosteric inhibitors of SHP2 for the treatment of cancer. European Journal of Medicinal Chemistry. 258. 115585–115585. 12 indexed citations
8.
Zhang, Yulu, Xiaojing Guo, Xin Huang, et al.. (2023). The Co-Association of Enterobacteriaceae and Pseudomonas with Specific Resistant Cucumber against Fusarium Wilt Disease. Biology. 12(2). 143–143. 8 indexed citations
9.
Li, Xingchen, Guidong Chen, Xiaojing Guo, et al.. (2023). Oncogenic PIK3CA recruits myeloid‐derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5‐lipoxygenase‐dependent arachidonic acid pathway. Clinical and Translational Medicine. 13(11). e1483–e1483. 17 indexed citations
10.
Liu, Zhenmi, Xi Wang, Chenxi Li, et al.. (2022). SP1 Promotes HDAC4 Expression and Inhibits HMGB1 Expression to Reduce Intestinal Barrier Dysfunction, Oxidative Stress, and Inflammatory Response after Sepsis. Journal of Innate Immunity. 14(4). 366–379. 13 indexed citations
11.
Liu, Fangfang, Kailiang Wu, Jelmar Quist, et al.. (2021). Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication. npj Breast Cancer. 7(1). 86–86. 12 indexed citations
12.
13.
Liu, Hai‐Ning, et al.. (2018). Effect of <i>Bushen yixue</i> decoction on follicular development in experimental androgen-sterilized anovulatory rats and its possible mechanism of action. Tropical Journal of Pharmaceutical Research. 17(4). 653–653. 1 indexed citations
14.
Zhang, Xinji, Yuan Zhang, Xiaofei Ye, et al.. (2016). Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry. BMJ Open. 6(11). e010643–e010643. 38 indexed citations
15.
Guo, Xiaojing, Yiqian Zhang, Qi Zhang, et al.. (2016). Clinicopathological characteristics of primary squamous cell carcinoma of breast. International Journal of Clinical and Experimental Pathology. 9(5). 5535–5543. 1 indexed citations
16.
Guo, Xiaojing, Xiaofei Ye, Xingxing Wang, et al.. (2015). Reporting patterns of adverse drug reactions over recent years in China: analysis from publications. Expert Opinion on Drug Safety. 14(2). 191–198. 20 indexed citations
17.
Guo, Xiaojing, Chunying Yang, Xiaolong Qian, et al.. (2013). Estrogen Receptor α Regulates ATM Expression through miRNAs in Breast Cancer. Clinical Cancer Research. 19(18). 4994–5002. 50 indexed citations
18.
Yang, Chunying, Michael Lee, Jianwei Hao, et al.. (2012). Deoxycytidine kinase regulates the G2/M checkpoint through interaction with cyclin-dependent kinase 1 in response to DNA damage. Nucleic Acids Research. 40(19). 9621–9632. 21 indexed citations
19.
Zhao, Jing, Ronggang Lang, Xiaojing Guo, et al.. (2009). Clinicopathologic characteristics of pleomorphic carcinoma of the breast. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 456(1). 31–37. 10 indexed citations
20.
Li, Xiaofang, et al.. (2006). [A study on the mechanism of drug resistance in Staphylococcus aureus].. PubMed. 37(3). 365–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary Gordon Breakdown of academic impact, for papers by Shengli Yang Breakdown of academic impact, for papers by Jaydutt V. Vadgama Breakdown of academic impact, for papers by Elaine Lai‐Han Leung Breakdown of academic impact, for papers by Liling Zhang Breakdown of academic impact, for papers by Si Sun Breakdown of academic impact, for papers by Saverio Candido Breakdown of academic impact, for papers by Haibo Wang Breakdown of academic impact, for papers by Neil Murphy Breakdown of academic impact, for papers by Howard H. Bailey
Rankless by CCL
2026